3 best performing ASX shares in week 12, 21 March 2022
Marc Kennis, March 26, 2022
Best performing ASX shares
The three best performing ASX shares in the week of 21 March 2022 were Imricor Medical Systems (ASX:IMR), up 72.5%, Volt Resources (ASX:VRC), up 50%, and Macarthur Minerals (ASX:MIO), up 41.5%.
GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER
1. Imricor Medical Systems (ASX:IMR)
Industry: Healthcare
Imricor Medical Systems Inc (ASX:IMR) is a US based medical device company that seeks to address the current issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The company’s primary product offering, the Vision-MR Ablation Catheter is specifically designed to work under real-time MRI guidance.
Market Cap: $99m
12 month high / low: $0.35 – $2.27
2. Volt Resources (ASX:VRC)
Industry: Resources
Volt Resources Limited (VRC) is a graphite exploration and development company listed on the Australian Stock Exchange. Volt is currently focused on the exploration and development of its wholly-owned Bunyu Graphite Project in Tanzania.
Market Cap: $51M
12 month high / low: $0.012 – $0.045
3. Macarthur Minerals (ASX:MIO)
Industry: Resources
Macarthur Minerals Limited (ASX:MIO) is an iron ore development, gold and lithium exploration company that is focused on bringing to production its 100% owned Western Australia iron ore projects. The Lake Giles Iron Project includes the 80 million tonne Ularring hematite resource (approved for development) and the 710 million tonne Moonshine magnetite resource.
Market Cap: $85
12 month high / low: $0.31 – $0.67
Learn more about ASX-listed stocks with
Stocks Down Under!
Subscribe to Stocks Down Under today!
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?
The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…